| Literature DB >> 33669364 |
Deborah Traversi1, Alessandra Pulliero2, Alberto Izzotti3,4, Elena Franchitti1, Licia Iacoviello5,6, Francesco Gianfagna5,7, Alessandro Gialluisi6, Benedetta Izzi6, Antonella Agodi8, Martina Barchitta8, Giovanna Elisa Calabrò9, Ilda Hoxhaj9, Michele Sassano9, Luca Gino Sbrogiò10, Annamaria Del Sole11, Francesco Marchiori12, Erica Pitini13, Giuseppe Migliara13, Carolina Marzuillo13, Corrado De Vito13, Manuela Tamburro14, Michela Lucia Sammarco14, Giancarlo Ripabelli14, Paolo Villari13, Stefania Boccia9,15.
Abstract
The development of high-throughput omics technologies represents an unmissable opportunity for evidence-based prevention of adverse effects on human health. However, the applicability and access to multi-omics tests are limited. In Italy, this is due to the rapid increase of knowledge and the high levels of skill and economic investment initially necessary. The fields of human genetics and public health have highlighted the relevance of an implementation strategy at a national level in Italy, including integration in sanitary regulations and governance instruments. In this review, the emerging field of public health genomics is discussed, including the polygenic scores approach, epigenetic modulation, nutrigenomics, and microbiomes implications. Moreover, the Italian state of implementation is presented. The omics sciences have important implications for the prevention of both communicable and noncommunicable diseases, especially because they can be used to assess the health status during the whole course of life. An effective population health gain is possible if omics tools are implemented for each person after a preliminary assessment of effectiveness in the medium to long term.Entities:
Keywords: early disease prevention; epigenetic modulations; genetic and microbiome markers; genetic polymorphisms; health technology assessment; miRNA; public health genomics
Year: 2021 PMID: 33669364 DOI: 10.3390/jpm11020135
Source DB: PubMed Journal: J Pers Med ISSN: 2075-4426